Khaled Ibrahim

769 total citations
8 papers, 107 citations indexed

About

Khaled Ibrahim is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Organic Chemistry. According to data from OpenAlex, Khaled Ibrahim has authored 8 papers receiving a total of 107 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 3 papers in Pulmonary and Respiratory Medicine and 1 paper in Organic Chemistry. Recurrent topics in Khaled Ibrahim's work include Cancer Treatment and Pharmacology (3 papers), HER2/EGFR in Cancer Research (2 papers) and Advanced Breast Cancer Therapies (1 paper). Khaled Ibrahim is often cited by papers focused on Cancer Treatment and Pharmacology (3 papers), HER2/EGFR in Cancer Research (2 papers) and Advanced Breast Cancer Therapies (1 paper). Khaled Ibrahim collaborates with scholars based in Lebanon, United States and Saudi Arabia. Khaled Ibrahim's co-authors include Jie Shen, Lingxiao Xie, Nizar Bitar, Ali Shamseddine, Nadine Haddad, Fadi Farhat, Hassan Hatoum, Joseph Kattan, Sally Temraz and Amr Nassar and has published in prestigious journals such as Journal of Clinical Oncology, Pharmaceutics and Future Oncology.

In The Last Decade

Khaled Ibrahim

8 papers receiving 106 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Khaled Ibrahim Lebanon	6	39	33	28	27	12	8	107
Pavel Pochop Czechia	7	18 0.5×	29 0.9×	23 0.8×	17 0.6×	6 0.5×	17	132
F. Moal France	6	38 1.0×	45 1.4×	13 0.5×	20 0.7×	8 0.7×	15	123
Yinmei Dai China	9	28 0.7×	66 2.0×	13 0.5×	10 0.4×	7 0.6×	27	267
G.J. Veldhuis Netherlands	5	24 0.6×	19 0.6×	15 0.5×	55 2.0×	8 0.7×	5	128
Raúl Ruiz Spain	4	89 2.3×	56 1.7×	87 3.1×	20 0.7×	34 2.8×	8	196
Dimitrios Veldekis Greece	5	58 1.5×	47 1.4×	39 1.4×	54 2.0×	48 4.0×	9	173
Pierre Chelle Canada	12	32 0.8×	44 1.3×	22 0.8×	9 0.3×	28 2.3×	31	352
Marnix Lameijer Netherlands	2	47 1.2×	45 1.4×	47 1.7×	10 0.4×	11 0.9×	2	141
Donglei Zhu China	6	31 0.8×	38 1.2×	36 1.3×	59 2.2×	53 4.4×	7	151

Countries citing papers authored by Khaled Ibrahim

Since Specialization

Citations

This map shows the geographic impact of Khaled Ibrahim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Khaled Ibrahim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Khaled Ibrahim more than expected).

Fields of papers citing papers by Khaled Ibrahim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Khaled Ibrahim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Khaled Ibrahim. The network helps show where Khaled Ibrahim may publish in the future.

Co-authorship network of co-authors of Khaled Ibrahim

This figure shows the co-authorship network connecting the top 25 collaborators of Khaled Ibrahim. A scholar is included among the top collaborators of Khaled Ibrahim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Khaled Ibrahim. Khaled Ibrahim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Ghosn, Marwan, Joseph Kattan, Fadi El Karak, et al.. (2023). Renal cell carcinoma management: real-world practice and challenges at a national level. Future Oncology. 19(12). 863–872. 2 indexed citations

Xie, Lingxiao, et al.. (2021). A Long-Acting Curcumin Nanoparticle/In Situ Hydrogel Composite for the Treatment of Uveal Melanoma. Pharmaceutics. 13(9). 1335–1335. 33 indexed citations

Ariffin, Hany, K.‐H. William Lau, Khaled Ibrahim, et al.. (2018). Young adult survivors of childhood acute lymphoblastic leukemia show evidence of chronic inflammation and cellular aging. Yearbook of pediatric endocrinology. 6 indexed citations

Farhat, Fadi, Sally Temraz, Joseph Kattan, et al.. (2011). Final results of a phase II study of liposomal cisplatin-vinorelbine combination as first-line treatment in HER2/neu negative metastatic breast cancer.. Journal of Clinical Oncology. 29(15_suppl). e11080–e11080. 1 indexed citations

Farhat, Fadi, Sally Temraz, Joseph Kattan, et al.. (2011). A Phase II Study of Lipoplatin (Liposomal Cisplatin)/Vinorelbine Combination in HER-2/neu–Negative Metastatic Breast Cancer. Clinical Breast Cancer. 11(6). 384–389. 35 indexed citations

Chaudhri, Naeem, Said Mohamed, Walid Rasheed, et al.. (2010). High efficacy and low toxicity of short-course oral valganciclovir as pre-emptive therapy for hematopoietic stem cell transplant cytomegalovirus infection. Hematology/Oncology and Stem Cell Therapy. 3(3). 116–120. 12 indexed citations

Farhat, Fadi, Khaled Ibrahim, Nizar Bitar, et al.. (2010). 457 Preliminary results of a phase II study of lipoplatin (liposomal cisplatin)–vinorelbine combination as first line treatment in HER2/neu negative metastatic breast cancer (MBC). European Journal of Cancer Supplements. 8(3). 192–192. 12 indexed citations

Farhat, Fadi, Khaled Ibrahim, Joseph Kattan, et al.. (2009). Preliminary results of a phase II study of liposomal cisplatin-vinorelbine combination as first-line treatment in HER2/neu negative metastatic breast cancer (MBC). Journal of Clinical Oncology. 27(15_suppl). 1068–1068. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact